1. Home
  2. MRUS vs HESM Comparison

MRUS vs HESM Comparison

Compare MRUS & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • HESM
  • Stock Information
  • Founded
  • MRUS 2003
  • HESM 2014
  • Country
  • MRUS Netherlands
  • HESM United States
  • Employees
  • MRUS N/A
  • HESM N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • HESM Oil & Gas Production
  • Sector
  • MRUS Health Care
  • HESM Energy
  • Exchange
  • MRUS Nasdaq
  • HESM Nasdaq
  • Market Cap
  • MRUS 5.1B
  • HESM 4.3B
  • IPO Year
  • MRUS 2016
  • HESM N/A
  • Fundamental
  • Price
  • MRUS $95.18
  • HESM $33.81
  • Analyst Decision
  • MRUS Buy
  • HESM Hold
  • Analyst Count
  • MRUS 18
  • HESM 9
  • Target Price
  • MRUS $93.72
  • HESM $41.44
  • AVG Volume (30 Days)
  • MRUS 1.9M
  • HESM 1.6M
  • Earning Date
  • MRUS 10-31-2025
  • HESM 11-03-2025
  • Dividend Yield
  • MRUS N/A
  • HESM 8.93%
  • EPS Growth
  • MRUS N/A
  • HESM 18.65
  • EPS
  • MRUS N/A
  • HESM 2.81
  • Revenue
  • MRUS $56,606,000.00
  • HESM $1,613,000,000.00
  • Revenue This Year
  • MRUS $52.81
  • HESM $12.47
  • Revenue Next Year
  • MRUS N/A
  • HESM $4.22
  • P/E Ratio
  • MRUS N/A
  • HESM $12.05
  • Revenue Growth
  • MRUS 57.54
  • HESM 10.78
  • 52 Week Low
  • MRUS $33.19
  • HESM $31.63
  • 52 Week High
  • MRUS $95.30
  • HESM $44.14
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 78.45
  • HESM 44.82
  • Support Level
  • MRUS $94.75
  • HESM $33.50
  • Resistance Level
  • MRUS $95.10
  • HESM $35.40
  • Average True Range (ATR)
  • MRUS 0.34
  • HESM 0.65
  • MACD
  • MRUS -0.91
  • HESM 0.27
  • Stochastic Oscillator
  • MRUS 86.67
  • HESM 46.10

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About HESM Hess Midstream LP Share

Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.

Share on Social Networks: